INVESTMENT
SICC Innvierte from CDTI Innovación, in collaboration with Sofinnova Capital X, is investing in Nuage Tx, a startup developing new drugs that target proteins previously considered undruggable (Intrinsically Disordered Proteins, IDPs)
The amount committed by CDTI Innovación is €1.8 million
Ver sección
The CDTI SICC Innvierte of Innovation invests, together with DRAPER B1 III RCF SMES, ARKADIA SPACE, company dedicated to the development of green propulsion systems
The input committed by the CDTI innovation is eur 360 000
Ver sección
The CDTI Innovation invests, together with NOLABEY GRUP, S.L. VIRTUAL BODYWORKS, S.L., whom he carried out a new proprietary technology KiinX Engine and Embodiment, offering training experiences immersive applications
The input committed by the CDTI innovation is €500,000
Ver sección
The Innovation and CDTI Suma Capital invested in WATTWIN, the platform which digitizes the sales of photovoltaic project
The input committed by the CDTI Innovation amounts to €540,000
Ver sección
The CDTI Innovation invests, together with SABADELL ASABYS HEALTH INNOVATION INVESTMENTS II, RCF and SABADELL ASABYS HEALTH INNOVATION INVESTMENTS 2B, SCR SA, QUIBIM, S.L., company biomedical technology
The input committed by the CDTI innovation is eur 2,500,000
Ver sección
El CDTI Innovación invierte en la empresa estratégica ONCOMATRYX BIOPHARMA S.L., pionera en el desarrollo de fármacos contra el microambiente tumoral
The input committed by the CDTI innovation is eur 10,000,000
Ver sección
El CDTI Innovación invierte, junto con INVEREADY BIOTECH IV S.C.R, S.A, INVEREADY BIOTECH IV PARELLEL S.C.R., S.A, e INVEREADY INNVIERTE CONVERTIBLE TECH NOTES I S.C.R, S.A., en GENIOVA TECHNOLOGIES S.L
The input committed by the CDTI innovation is eur 3.6 million
Ver sección
The CDTI invests, together with NARA CAPITAL, in Tesai Care SL, medical devices to prevent and treat respiratory muscle atrophy electrostimulation with non-invasive
The input committed by the CDTI innovation is €270,000
Ver sección
The CDTI invests together with Ysios Capital and Asabys Partners in Anaconda Biomed, medical devices company neurovasculares
The input committed by the CDTI Innovation is eur 3.6 million
Ver sección
Subscribe to INVESTMENT